Copyright Reports & Markets. All rights reserved.

Global In Vitro Lung Fibrosis Model Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global In Vitro Lung Fibrosis Model Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 2D Model
    • 1.3.3 3D Model
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global In Vitro Lung Fibrosis Model Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Discovery & Toxicology Studies
    • 1.4.3 Physiological Research
    • 1.4.4 3D Model Development
    • 1.4.5 Others
  • 1.5 Global In Vitro Lung Fibrosis Model Market Size & Forecast
    • 1.5.1 Global In Vitro Lung Fibrosis Model Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global In Vitro Lung Fibrosis Model Sales Quantity (2021-2032)
    • 1.5.3 Global In Vitro Lung Fibrosis Model Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Epithelix
    • 2.1.1 Epithelix Details
    • 2.1.2 Epithelix Major Business
    • 2.1.3 Epithelix In Vitro Lung Fibrosis Model Product and Services
    • 2.1.4 Epithelix In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Epithelix Recent Developments/Updates
  • 2.2 MATTEK
    • 2.2.1 MATTEK Details
    • 2.2.2 MATTEK Major Business
    • 2.2.3 MATTEK In Vitro Lung Fibrosis Model Product and Services
    • 2.2.4 MATTEK In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 MATTEK Recent Developments/Updates
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza In Vitro Lung Fibrosis Model Product and Services
    • 2.3.4 Lonza In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lonza Recent Developments/Updates
  • 2.4 Emulate
    • 2.4.1 Emulate Details
    • 2.4.2 Emulate Major Business
    • 2.4.3 Emulate In Vitro Lung Fibrosis Model Product and Services
    • 2.4.4 Emulate In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Emulate Recent Developments/Updates
  • 2.5 AlveoliX AG
    • 2.5.1 AlveoliX AG Details
    • 2.5.2 AlveoliX AG Major Business
    • 2.5.3 AlveoliX AG In Vitro Lung Fibrosis Model Product and Services
    • 2.5.4 AlveoliX AG In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AlveoliX AG Recent Developments/Updates
  • 2.6 Nortis
    • 2.6.1 Nortis Details
    • 2.6.2 Nortis Major Business
    • 2.6.3 Nortis In Vitro Lung Fibrosis Model Product and Services
    • 2.6.4 Nortis In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Nortis Recent Developments/Updates
  • 2.7 CN Bio Innovations Ltd.
    • 2.7.1 CN Bio Innovations Ltd. Details
    • 2.7.2 CN Bio Innovations Ltd. Major Business
    • 2.7.3 CN Bio Innovations Ltd. In Vitro Lung Fibrosis Model Product and Services
    • 2.7.4 CN Bio Innovations Ltd. In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 CN Bio Innovations Ltd. Recent Developments/Updates
  • 2.8 MIMETAS
    • 2.8.1 MIMETAS Details
    • 2.8.2 MIMETAS Major Business
    • 2.8.3 MIMETAS In Vitro Lung Fibrosis Model Product and Services
    • 2.8.4 MIMETAS In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MIMETAS Recent Developments/Updates
  • 2.9 InSphero
    • 2.9.1 InSphero Details
    • 2.9.2 InSphero Major Business
    • 2.9.3 InSphero In Vitro Lung Fibrosis Model Product and Services
    • 2.9.4 InSphero In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 InSphero Recent Developments/Updates
  • 2.10 ATTC Global
    • 2.10.1 ATTC Global Details
    • 2.10.2 ATTC Global Major Business
    • 2.10.3 ATTC Global In Vitro Lung Fibrosis Model Product and Services
    • 2.10.4 ATTC Global In Vitro Lung Fibrosis Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ATTC Global Recent Developments/Updates

3 Competitive Environment: In Vitro Lung Fibrosis Model by Manufacturer

  • 3.1 Global In Vitro Lung Fibrosis Model Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global In Vitro Lung Fibrosis Model Revenue by Manufacturer (2021-2026)
  • 3.3 Global In Vitro Lung Fibrosis Model Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of In Vitro Lung Fibrosis Model by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 In Vitro Lung Fibrosis Model Manufacturer Market Share in 2025
    • 3.4.3 Top 6 In Vitro Lung Fibrosis Model Manufacturer Market Share in 2025
  • 3.5 In Vitro Lung Fibrosis Model Market: Overall Company Footprint Analysis
    • 3.5.1 In Vitro Lung Fibrosis Model Market: Region Footprint
    • 3.5.2 In Vitro Lung Fibrosis Model Market: Company Product Type Footprint
    • 3.5.3 In Vitro Lung Fibrosis Model Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global In Vitro Lung Fibrosis Model Market Size by Region
    • 4.1.1 Global In Vitro Lung Fibrosis Model Sales Quantity by Region (2021-2032)
    • 4.1.2 Global In Vitro Lung Fibrosis Model Consumption Value by Region (2021-2032)
    • 4.1.3 Global In Vitro Lung Fibrosis Model Average Price by Region (2021-2032)
  • 4.2 North America In Vitro Lung Fibrosis Model Consumption Value (2021-2032)
  • 4.3 Europe In Vitro Lung Fibrosis Model Consumption Value (2021-2032)
  • 4.4 Asia-Pacific In Vitro Lung Fibrosis Model Consumption Value (2021-2032)
  • 4.5 South America In Vitro Lung Fibrosis Model Consumption Value (2021-2032)
  • 4.6 Middle East & Africa In Vitro Lung Fibrosis Model Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 5.2 Global In Vitro Lung Fibrosis Model Consumption Value by Type (2021-2032)
  • 5.3 Global In Vitro Lung Fibrosis Model Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 6.2 Global In Vitro Lung Fibrosis Model Consumption Value by Application (2021-2032)
  • 6.3 Global In Vitro Lung Fibrosis Model Average Price by Application (2021-2032)

7 North America

  • 7.1 North America In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 7.2 North America In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 7.3 North America In Vitro Lung Fibrosis Model Market Size by Country
    • 7.3.1 North America In Vitro Lung Fibrosis Model Sales Quantity by Country (2021-2032)
    • 7.3.2 North America In Vitro Lung Fibrosis Model Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 8.2 Europe In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 8.3 Europe In Vitro Lung Fibrosis Model Market Size by Country
    • 8.3.1 Europe In Vitro Lung Fibrosis Model Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe In Vitro Lung Fibrosis Model Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific In Vitro Lung Fibrosis Model Market Size by Region
    • 9.3.1 Asia-Pacific In Vitro Lung Fibrosis Model Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific In Vitro Lung Fibrosis Model Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 10.2 South America In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 10.3 South America In Vitro Lung Fibrosis Model Market Size by Country
    • 10.3.1 South America In Vitro Lung Fibrosis Model Sales Quantity by Country (2021-2032)
    • 10.3.2 South America In Vitro Lung Fibrosis Model Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa In Vitro Lung Fibrosis Model Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa In Vitro Lung Fibrosis Model Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa In Vitro Lung Fibrosis Model Market Size by Country
    • 11.3.1 Middle East & Africa In Vitro Lung Fibrosis Model Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa In Vitro Lung Fibrosis Model Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 In Vitro Lung Fibrosis Model Market Drivers
  • 12.2 In Vitro Lung Fibrosis Model Market Restraints
  • 12.3 In Vitro Lung Fibrosis Model Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of In Vitro Lung Fibrosis Model and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of In Vitro Lung Fibrosis Model
  • 13.3 In Vitro Lung Fibrosis Model Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 In Vitro Lung Fibrosis Model Typical Distributors
  • 14.3 In Vitro Lung Fibrosis Model Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global In Vitro Lung Fibrosis Model market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    In vitro lung fibrosis models are experimental systems designed to simulate and study the development and progression of lung fibrosis outside of a living organism. Lung fibrosis, characterized by the excessive accumulation of fibrous tissue in the lungs, is a common feature of various respiratory diseases, such as idiopathic pulmonary fibrosis
    In vitro lung fibrosis models typically involve the use of cultured cells, tissues, or three-dimensional (3D) constructs that mimic the complex microenvironment of the lung. These models aim to replicate key aspects of lung fibrosis, including fibroblast activation, extracellular matrix deposition, and the inflammatory response. Researchers use these models to investigate the underlying mechanisms of fibrosis, screen potential anti-fibrotic drugs, and explore novel therapeutic strategies.
    This report is a detailed and comprehensive analysis for global In Vitro Lung Fibrosis Model market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global In Vitro Lung Fibrosis Model market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global In Vitro Lung Fibrosis Model market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global In Vitro Lung Fibrosis Model market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global In Vitro Lung Fibrosis Model market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for In Vitro Lung Fibrosis Model
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global In Vitro Lung Fibrosis Model market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd., MIMETAS, InSphero, ATTC Global, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    In Vitro Lung Fibrosis Model market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    2D Model
    3D Model
    Market segment by Application
    Drug Discovery & Toxicology Studies
    Physiological Research
    3D Model Development
    Others
    Major players covered
    Epithelix
    MATTEK
    Lonza
    Emulate
    AlveoliX AG
    Nortis
    CN Bio Innovations Ltd.
    MIMETAS
    InSphero
    ATTC Global
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe In Vitro Lung Fibrosis Model product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of In Vitro Lung Fibrosis Model, with price, sales quantity, revenue, and global market share of In Vitro Lung Fibrosis Model from 2021 to 2026.
    Chapter 3, the In Vitro Lung Fibrosis Model competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the In Vitro Lung Fibrosis Model breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and In Vitro Lung Fibrosis Model market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of In Vitro Lung Fibrosis Model.
    Chapter 14 and 15, to describe In Vitro Lung Fibrosis Model sales channel, distributors, customers, research findings and conclusion.

    Buy now